Mirae Asset Global Investments’s Ventyx Biosciences VTYX Stock Holding History

Mirae Asset Global Investments’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,468	Closed	-$31.3K	–	1740
2025 Q4	$31.3K	Buy	+3,468	New	+$25.9K	﹤0.01%	1480
2024 Q4	–	Sell	-2,556	Closed	-$5.9K	–	1684
2024 Q3	$5.9K	Buy	2,556 +451	+21%	+$1.04K	﹤0.01%	1516
2024 Q2	$5.03K	Sell	2,105 -11,064	-84%	-$46K	﹤0.01%	1491
2024 Q1	$404K	Buy	+13,169	New	+$60.2K	﹤0.01%	1995
2023 Q4	–	Sell	-22,617	Closed	-$785K	–	2609
2023 Q3	$785K	Buy	22,617 +59	+0.3%	+$2.04K	﹤0.01%	1657
2023 Q2	$740K	Buy	22,558 +9,751	+76%	+$336K	﹤0.01%	1753
2023 Q1	$429K	Sell	12,807 -36	-0.3%	-$1.4K	﹤0.01%	2003
2022 Q4	$421K	Buy	12,843 +1,433	+13%	+$42.4K	﹤0.01%	1981
2022 Q3	$398K	Buy	+11,410	New	+$253K	﹤0.01%	2009

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mirae Asset Global Investments's VTYX Position: Q1 2026 in Review

Mirae Asset Global Investments sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 3,468 shares — an estimated $31.3K sold.

Mirae Asset Global Investments first reported a position in VTYX in Q3 2022 and held it in 9 quarters. The position peaked at $785K in Q3 2023. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Mirae Asset Global Investments reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Mirae Asset Global Investments sold 3,468 Ventyx Biosciences shares in Q1 2026, an estimated $31.3K.
Mirae Asset Global Investments first reported a position in Ventyx Biosciences in Q3 2022 and held it in 9 quarters.
Mirae Asset Global Investments's Ventyx Biosciences position peaked at $785K in Q3 2023.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Mirae Asset Global Investments's 13F filing for Q1 2026, filed 4 May 2026.